---
title: "SRNE.US (SRNE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SRNE.US/news.md"
symbol: "SRNE.US"
name: "SRNE.US"
parent: "https://longbridge.com/en/quote/SRNE.US.md"
datetime: "2026-03-05T00:41:27.856Z"
locales:
  - [en](https://longbridge.com/en/quote/SRNE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SRNE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SRNE.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SRNE.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SRNE.US/news.md)


# SRNE.US (SRNE.US) — Related News

### [Immuno-oncology biotechnology company Salspera sets its U.S. IPO price at $14 to $16 per share, aiming to raise $85 million](https://longbridge.com/en/news/276694398.md)
*2026-02-24T07:02:03.000Z*
> Immuno-oncology biotechnology company Salspera plans to conduct an initial public offering (IPO) on the US stock market,

### [Santhera Appoints Stifel as Corporate Finance Advisor](https://longbridge.com/en/news/275409379.md)
*2026-02-10T06:05:30.000Z*
> (MORE TO FOLLOW) Dow Jones Newswires February 10, 2026 01:00 ET (06:00 GMT)

### [Sorrento Resources Raising C$2 Million in a Private Placement of Share Units; Shares down 9.3%](https://longbridge.com/en/news/274856216.md)
*2026-02-04T18:28:00.000Z*
> Sorrento Resources is raising up to C$2 million through a non-brokered private placement of share units, offering up to 

### [DiaSorin Submits LIAISON NES Group A Strep Test to FDA for 510(k) Clearance and CLIA Waiver](https://longbridge.com/en/news/274643904.md)
*2026-02-03T11:14:38.000Z*
> DiaSorin S.p.A. has submitted a 510(k) premarket notification and CLIA waiver application to the FDA for its LIAISON NES

### [Sorrento Therapeutics  ( NASDAQ:SRNE )  Earns Hold Rating from Analysts at StockNews.com](https://longbridge.com/en/news/207754918.md)
*2024-07-02T08:40:39.000Z*
> StockNews.com initiated coverage on shares of Sorrento Therapeutics ( NASDAQ:SRNE - Get Free Report ) in a report releas

### [Virpax Pharmaceuticals Announces Proposed Settlement Of Litigation With Sorrento Therapeutics And Scilex Pharmaceuticals](https://longbridge.com/en/news/108731361.md)
*2024-02-27T12:43:01.000Z*
> Feb 27 (Reuters) - Virpax Pharmaceuticals Inc:* VIRPAX PHARMACEUTICALS ANNOUNCES PROPOSED SETTLEMENT OF LITIGATION WITH 

### [Health Care Slips on Growth Doubts -- Health Care Roundup](https://longbridge.com/en/news/108668860.md)
*2024-02-26T22:35:18.000Z*
> Health-care companies slipped amid doubts about the outlook for growth. Lawyers for biopharmaceutical company Sorrento T

### [Sorrento Therapeutics  ( NASDAQ:SRNE )  Receives New Coverage from Analysts at StockNews.com](https://longbridge.com/en/news/99712356.md)
*2023-10-12T08:01:26.000Z*
> Sorrento Therapeutics ( NASDAQ:SRNE ) Receives New Coverage ...

### [Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20](https://longbridge.com/en/news/98636582.md)
*2023-09-26T21:43:17.000Z*
> Sept 26 (Reuters) - Sorrento Therapeutics Inc (SRNEQ.PK) :
* SORRENTO THERAPEUTICS INC- ON SEPTEMBER 20, 2023, SORRENTO 

### [StockNews.com Initiates Coverage on Sorrento Therapeutics  ( NASDAQ:SRNE ) ](https://longbridge.com/en/news/97933894.md)
*2023-09-18T08:02:28.000Z*
> StockNews.com Initiates Coverage on Sorrento Therapeutics ..